Inventor · disambiguated record
Meinhard Hasslacher
Also filed as: HASSLACHER MEINHARD
35 granted patents·6 pending applications·115 citations·filing 2007–2023
96Inventor score
Top patents by PatentIndex Score
41 records- 0196US8313926B2Methods for expressing ADAMTS proteins in cell culture medium supplemented with zincGRILLBERGER LEOPOLD·Filed 2010·Granted Nov 20, 2012·34 cites·30 claims
- 0295US9127265B2Cell culture medium for ADAMTS protein expressionBAXTER INT·Filed 2014·Granted Sep 8, 2015·19 cites·29 claims
- 0395US8759026B2Methods for increasing recovery of an ADAMTS activity from a cell culture supernatantBAXTER INT·Filed 2012·Granted Jun 24, 2014·15 cites·32 claims
- 0492US9441216B2Cell culture medium for ADAMTS protein expressionBAXALTA INC·Filed 2015·Granted Sep 13, 2016·5 cites·25 claims
- 0590US10072254B2Cell culture methods for expressing ADAMTS13 proteinBAXALTA INC·Filed 2016·Granted Sep 11, 2018·3 cites·19 claims
- 0689US9315560B2Purification of VWF for increased removal of non-lipid enveloped virusesMITTERER ARTUR·Filed 2010·Granted Apr 19, 2016·11 cites·9 claims
- 0786US12492390B2Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Granted Dec 9, 2025·0 cites·35 claims
- 0885US10724024B2Cell culture methods for expressing ADAMTS proteinBAXALTA INC·Filed 2018·Granted Jul 28, 2020·1 cites·20 claims
- 0983US10723761B2Protein purification by anion exchange chromatographyBAXALTA INC·Filed 2017·Granted Jul 28, 2020·2 cites·17 claims
- 1083US8945895B2Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereofHASSLACHER MEINHARD·Filed 2010·Granted Feb 3, 2015·7 cites·19 claims
- 1182US8388847B2Methods of concentrating shear-sensitive biopolymersMITTERER ARTUR·Filed 2009·Granted Mar 5, 2013·6 cites·13 claims
- 1278US8399632B2Method for the purification of recombinant blood coagulation factor IX enriched in sulfated and/or phosphorylated moleculesMITTERER ARTUR·Filed 2008·Granted Mar 19, 2013·2 cites·19 claims
- 1377US11661593B2Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereofTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted May 30, 2023·1 cites·11 claims
- 1476US11981934B2Adeno-associated virus purification methodsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted May 14, 2024·1 cites·29 claims
- 1576US8148502B2R-ALPHA1 antitrypsin anion exchange chromatographyMITTERER ARTUR·Filed 2007·Granted Apr 3, 2012·2 cites·13 claims
- 1675US11254921B2ADAMTS13 protein cell culture supernatantTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Feb 22, 2022·0 cites·22 claims
- 1775US8058411B2Method for producing mature VWF from VWF pro-peptideMUNDT WOLFGANG·Filed 2008·Granted Nov 15, 2011·4 cites·30 claims
- 1870US11421202B2Virus filtration of cell culture mediaTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Aug 23, 2022·0 cites·49 claims
- 1970US9670456B2Virus filtration of cell culture mediaBaxalta GmbH·Filed 2013·Granted Jun 6, 2017·1 cites·19 claims
- 2068US12257277B2Adeno-associated virus formulationsTAKEDA PHARMACEUTICALS CO·Filed 2023·Granted Mar 25, 2025·0 cites·27 claims
- 2166US12071468B2Purification of Factor VIII subspeciesTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Aug 27, 2024·0 cites·16 claims
- 2264US12246047B2Adeno-associated virus purification methodsTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Mar 11, 2025·0 cites·51 claims
- 2362US10934340B2Separation of VWF and VWF propeptide by chromatographic methodsBAXALTA INC·Filed 2019·Granted Mar 2, 2021·0 cites·28 claims
- 2461US9127264B2Substantially animal protein-free recombinant furin and methods for producing the samePLAIMAUER BARBARA·Filed 2010·Granted Sep 8, 2015·1 cites·12 claims
- 2561US2022041693A1Separation of vwf and vwf propeptide by chromatographic methodsTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 2659US2017260498A1Virus filtration of cell culture mediaBaxalta GmbH·Filed 2017·Application pending·0 cites
- 2758US11299533B2Purification of factor VIII subspeciesTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Apr 12, 2022·0 cites·9 claims
- 2858US9701710B2Protein purification by anion exchange chromatographyBAXALTA INC·Filed 2012·Granted Jul 11, 2017·0 cites·17 claims
- 2958US2025002868A1Adeno-associated virus separation on a cation exchangerTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 3056US11000561B2Adeno-associated virus purification methodsTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted May 11, 2021·0 cites·47 claims
- 3156US2009181423A1Substantially animal protein-free recombinant furin and methods for producing sameBAXTER INT·Filed 2008·Application pending·0 cites
- 3255US11583563B2Adeno-associated virus formulationsTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Feb 21, 2023·0 cites·24 claims
- 3354US9662376B2Formulations of recombinant furinBAXALTA INC·Filed 2014·Granted May 30, 2017·0 cites·29 claims
- 3454US2013150557A1Method for the purification of recombinant blood coagulation factor ix enriched in sulfated and/or phosphorylated moleculesBAXTER INT·Filed 2013·Application pending·0 cites
- 3551US2022267796A1Adeno-associated virus purification methodsTAKEDA PHARMACEUTICALS CO·Filed 2020·Application pending·0 cites
- 3648US8143347B2Pegylation of recombinant blood coagulation factors in the presence of bound antibodiesMITTERER ARTUR·Filed 2009·Granted Mar 27, 2012·0 cites·7 claims
- 3746US8877473B2Formulations of recombinant furinHASSLACHER MEINHARD·Filed 2012·Granted Nov 4, 2014·0 cites·28 claims
- 3845US10378004B2Protein purification by anion exchange chromatographyBAXALTA INC·Filed 2012·Granted Aug 13, 2019·0 cites·17 claims
- 3944US10202417B2Purification method for vitamin K dependent proteins by anion exchange chromatographyBAXALTA INC·Filed 2014·Granted Feb 12, 2019·0 cites·9 claims
- 4044US10036002B2Factor X activationBAXALTA INC·Filed 2015·Granted Jul 31, 2018·0 cites·21 claims
- 4138US10202416B2Purification method for divalent cation binding proteins on anion exchange resinMITTERER ARTUR·Filed 2011·Granted Feb 12, 2019·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Meinhard Hasslacher files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →